 |
 |
 |
 |
 |
|
|
| Article 1 to 6 out of 6 concerning Evotec AG
|
-
Evotec to Launch its First Innovation Centre for Fragment Based Drug Discovery
(24 May 2007)
Evotec AG announced the launch of its Innovation Centre for Fragment Based Drug Discovery ('FBDD'). FBDD offers an alternative approach for identifying novel, small molecule hits (fragments) for a number of biological targets including those that ...
-
PerkinElmer to Acquire Evotec Technologies
(04 Dec 2006)
PerkinElmer, Inc. announced that it has signed a definitive agreement with Evotec AG to acquire its majority owned subsidiary, Evotec Technologies GmbH, in a cash transaction valued at approximately EUR 23 million. The transaction is subject to ...
-
Evotec Sells Single Molecule Detection Technology & IP Portfolio to Olympus
(25 Jul 2006)
Evotec AG announced that its Tools and Technologies Division (Evotec Technologies GmbH) has sold the core of its Single Molecule Detection Technology and transferred or licensed the corresponding IP portfolio to Olympus Corporation, Tokyo, Japan. ...
-
Evotec and Roche Form Global Alliance to Jointly Discover Novel Drugs
(22 Jun 2006)
Roche and Evotec AG announced that they have formed an alliance to jointly discover and develop compounds against a target for CNS diseases and other indications. Leveraging the expertise developed by Evotec on this target, and as part of their CNS ...
-
Evotec OAI to Provide Process Validation for AnorMED Inc. Phase III Compound, AMD 3100
(18 Feb 2005)
Evotec OAI AG announced that AnorMED Inc has selected Evotec OAI to support AnorMED with the chemical development of its candidate AMD 3100, currently under evaluation in the clinic in stem cell mobilisation for stem cell transplantation in cancer ...
-
Evotec OAI and Rib-X Pharmaceuticals Enter Into Medicinal Chemistry Collaboration
(16 Jan 2004)
Evotec OAI AG and Rib-X Pharmaceuticals, Inc., announced the formation of a medicinal chemistry partnership.Scientists from Rib-X and Evotec OAI will collaborate on several research programmes. Evotec OAI will be utilising its state-of-the-art ...
 |
|
|
|
|